1. Home
  2. BMEA vs SFBC Comparison

BMEA vs SFBC Comparison

Compare BMEA & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

N/A

Current Price

$1.73

Market Cap

115.2M

Sector

Health Care

ML Signal

N/A

Logo Sound Financial Bancorp Inc.

SFBC

Sound Financial Bancorp Inc.

HOLD

Current Price

$46.80

Market Cap

103.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMEA
SFBC
Founded
2017
1953
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
115.2M
103.8M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
BMEA
SFBC
Price
$1.73
$46.80
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$9.83
N/A
AVG Volume (30 Days)
1.4M
14.3K
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
2.04%
EPS Growth
69.19
53.89
EPS
N/A
1.59
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$29.76
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$40.68
52 Week High
$2.99
$49.21

Technical Indicators

Market Signals
Indicator
BMEA
SFBC
Relative Strength Index (RSI) 75.92 57.43
Support Level $1.23 $41.29
Resistance Level $1.69 $48.04
Average True Range (ATR) 0.11 0.57
MACD 0.04 -0.02
Stochastic Oscillator 72.03 75.88

Price Performance

Historical Comparison
BMEA
SFBC

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

Share on Social Networks: